NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: The Scott Partnership
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thermo Fisher Scientific Launches New Single Quadrupole GC-MS with Removable Ion Source at Analytica - Thermo Fisher Scientific, Inc., announced the new Thermo Scientific ISQ single quadrupole gas chromatography-mass spectrometry (GC-MS) system with a unique, non-venting full-source removal capability (NYSE: TMO)
Thermo Fisher Scientific Launches New Single Quadrupole GC-MS with Removable Ion Source at Analytica

 

NewswireToday - /newswire/ - Munich, Germany, 2010/03/24 - Thermo Fisher Scientific, Inc., announced the new Thermo Scientific ISQ single quadrupole gas chromatography-mass spectrometry (GC-MS) system with a unique, non-venting full-source removal capability (NYSE: TMO).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the new Thermo Scientific ISQ single quadrupole gas chromatography-mass spectrometry (GC-MS) system with a unique, non-venting full-source removal capability. Featuring the new ExtractaBrite ion source, the ISQ system offers simplified operation and maximum uptime for uninterrupted productivity across routine GC-MS applications including forensics, toxicology, food safety and environmental.

Thermo Fisher will showcase the new GC-MS within Thermo Scientific booth 101 in Hall B1 during Analytica 2010, being held March 23-26 in Munich, Germany.

The ISQ GC-MS is a highly robust and rugged system that provides high-throughput sample analyses and 24/7 operation. The new ExtractaBrite removable ion source is designed to provide maximum uptime and productivity by extending the length of time between required source maintenance. When the system requires maintenance, the time-consuming and labor intensive procedures including breaking the vacuum, cooling off, cleaning, reassembling and restoring associated with conventional systems are eliminated. The entire ion source can be removed without venting the analyzer. The new ISQ single quadrupole GC-MS also offers an extended mass range, from 1.2 to 1100 u, for analyses across a varied range of compounds.

The ISQ system is ideally-suited for today's fast-paced gas chromatography methods. Advanced electronics allow the ISQ to acquire and write data to disc at accelerated rates for truly high-speed acquisition in real-world applications. The sequential full scan/selected ion monitoring (SIM) capability provides qualitative and quantitative analyses in a single injection, for confirmation and screening in the same analytical run.

With the ISQ GC-MS, labs are able to operate continuously and productivity can be considerably improved. The innovative ISQ GC-MS represents the most advanced technology available today while providing the opportunity for future upgrades and options. The ISQ mass spectrometer is offered with either the Thermo Scientific FOCUS GC for routine GC-MS or with the full-featured TRACE GC Ultra for improved flexibility and performance.

The ISQ GC-MS comes standard with the latest version of the Thermo Scientific QuanLab Forms GC-MS acquisition, analysis and reporting software package. QuanLab Forms 3.0 is an easy-to-use software solution that improves productivity through workflow-oriented acquisition, review and reporting features. Two additional software options, Thermo Scientific EnviroLab Forms 3.0 and ToxLab Forms 3.0, are also available with the system.

For more information about the new Thermo Scientific ISQ single quadrupole GC-MS, please visit Thermo Scientific booth 101 in Hall B1 at Analytica 2010.

For access to all Thermo Fisher Scientific news and product photos related to Analytica 2010, please visit the online media room

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (thermofisher.com) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Launches New Single Quadrupole GC-MS with Removable Ion Source at Analytica

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Celine Callender - Scottpr.com 
+44(0)14 7753 9539 analyze[.]thermofisher.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer
Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Market Finds Frost & Sullivan
Health Tech Company Hologram Sciences Launches Personalized Health & Nutrition Innovation with 0 Million Backing

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MONOVERSE USA, Inc.

Visit  BizJobs.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)